We present a case of a 46-year-old patient with an HCV-associated, multilocular hepatocellular carcinoma. Therapy with Sorafenib was discontinued as a result of serious side
We present a case of a 46-year-old patient with an HCV-associated, multilocular hepatocellular carcinoma. Therapy with Sorafenib was discontinued as a result of serious side